Official UK visa sponsor profile for Complement Therapeutics Limited in London, including current register status, route details, and public company data.
Complement Therapeutics Limited is a focused, research-driven biotechnology company specializing in the development of novel therapeutics. Established in 2020, the company operates from its headquarters at 4th Floor, Translation and Innovation Hub, 84 Wood Lane, London, W12 0BZ, UK. Complement’s core business revolves around identifying and validating novel targets for disease treatment, utilizing a combination of advanced molecular biology, drug discovery, and preclinical research. The company’s primary focus is on identifying and developing innovative therapies for unmet medical needs, particularly within the areas of oncology and immunology. Complement Therapeutics is currently active with a team of skilled researchers and scientists dedicated to advancing its pipeline of promising drug candidates. The company’s international presence is currently limited, primarily focused on research collaborations and strategic partnerships. Currently, Complement operates within the SIC codes of – 72110 (Research and experimental development on biotechnology) and – 21010 (Pharmaceutical research and development). The company’s size estimate is relatively small, reflecting its concentrated research efforts.
Official UK visa sponsor profile for Complement Therapeutics Limited in London, including current register status, route details, and public company data.
Complement Therapeutics Limited is a focused, research-driven biotechnology company specializing in the development of novel therapeutics. Established in 2020, the company operates from its headquarters at 4th Floor, Translation and Innovation Hub, 84 Wood Lane, London, W12 0BZ, UK. Complement’s core business revolves around identifying and validating novel targets for disease treatment, utilizing a combination of advanced molecular biology, drug discovery, and preclinical research. The company’s primary focus is on identifying and developing innovative therapies for unmet medical needs, particularly within the areas of oncology and immunology. Complement Therapeutics is currently active with a team of skilled researchers and scientists dedicated to advancing its pipeline of promising drug candidates. The company’s international presence is currently limited, primarily focused on research collaborations and strategic partnerships. Currently, Complement operates within the SIC codes of – 72110 (Research and experimental development on biotechnology) and – 21010 (Pharmaceutical research and development). The company’s size estimate is relatively small, reflecting its concentrated research efforts.
Yes, Complement Therapeutics Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Complement Therapeutics Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Complement Therapeutics Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Complement Therapeutics Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.